Non-proprietary Therapeutic Product (NTP) (English, French, CSV)

Non-proprietary Therapeutic Product (NTP): English/French CSV file you can open as a table, filter, chart and export up to 10,000 rows. From Health Canada, updated Jul 2024.

Format
CSV
Access
Table on demand (prepared when opened)
Publisher-reported update
2024-07-05

The Canadian Clinical Drug Dataset is a drug terminology and coding system designed to allow the interchange of standardized drug and medical device information between diverse digital health systems. Some use cases include electronic prescribing, electronic medical records, medication reconciliation and analytics. It also provides for the classification and identification of defined groups of medications (called special groupings), such as narcotic and controlled drugs. It has the capacity to be used by knowledge-based vendors, clinicians, researchers, statistical users, government agencies, healthcare organisations and consumers. The data source for the CCDD is the Drug Product Database (DPD) which contains information on drugs approved by Health Canada. However, the data is modeled differently following the CCDD Editorial Guidelines which take into consideration international terminology standards. For example, DPD uses the dosage form, “tablet (delayed-release)”, whereas CCDD uses the equivalent term “gastro-resistant tablet.” The Canadian Clinical Drug Data Set does not replace the Health Canada Drug Product Database (DPD) but is published in addition to it. The scope of…

Access original file

Data overview

Formats
CSV
File languages
English, French
Available actions
Explore table (prepared automatically) · Access original file

Sample rows

The first 10 rows, as CanQuery read them from the start of the publisher's file on 2026-11-01.

ntp_codentp_formal_namentp_en_descriptionntp_fr_descriptionntp_statusntp_status_effective_timentp_type
9001494primaquine phosphate 26.3 mg oral tabletNAphosphate de primaquine 26,3 mg comprimé oralActive19451231NA
9012957dihydroergotamine mesylate 1 mg per 1 mL solution for injection ampouleNAmésylate de dihydroergotamine 1 mg par 1 mL solution injectable ampouleActive19461231NA
9001497bismuth dipropylacetate 135 mg suppositoryNAdipropylacétate de bismuth 135 mg suppositoireActive19501231NA
9000003epinephrine (epinephrine hydrochloride) 1 mg per 1 mL solution for injection ampouleNAépinéphrine (chlorhydrate d'épinéphrine) 1 mg par 1 mL solution injectable ampouleActive19511231NA
9001534tropicamide 0.5 % ophthalmic dropsNAtropicamide 0,5 % gouttes ophtalmiquesActive19511231NA
9001498acetylsalicylic acid 325 mg gastro-resistant tabletNAacide acétylsalicylique 325 mg comprimé gastrorésistantActive19511231NA
9001512dimenhydrinate 15 mg per 5 mL syrupNAdimenhydrinate 15 mg par 5 mL siropActive19511231NA
9001536white petrolatum 100 % cutaneous ointmentNApétrolatum blanc 100 % pommade cutanéeActive19511231NA
9015026epinephrine (epinephrine hydrochloride) 30 mg per 30 mL solution for injection vialNAépinéphrine (chlorhydrate d'épinéphrine) 30 mg par 30 mL solution injectable fioleActive19511231NA
9014635epinephrine (epinephrine hydrochloride) 1 mg per mL cutaneous solutionNAépinéphrine (chlorhydrate d'épinéphrine) 1 mg par mL solution pour application cutanéeActive19511231NA

Official sources and licences

Related open data